Procter & Gamble Health Care CEO Jennifer Davis to Retire

Dow Jones
Dec 15

By Connor Hart

 

The head of Procter & Gamble's health care division will retire next year.

The maker of Tide laundry detergent and Crest toothpaste said Monday that Jennifer Davis will retire effective June 30, 2026, following more than three decades with the company.

Davis' retirement follows several executive changes at the packaged-goods company this summer. P&G previously said Alexandra Keith would retire as chief executive of its global beauty business early next year, and it named Shailesh Jejurikar its new top officer.

P&G's health care business includes oral care brands such as Crest and Oral-B, as well as personal health care brands including Pepto-Bismol and Vicks. The unit accounted for 14% of the company's roughly $84 billion in sales during its fiscal year ended June 30, 2025, according to the company's latest annual filing with the Securities and Exchange Commission.

The company disclosed Davis' planned retirement but didn't indicate any succession plans.

David joined P&G in 1993 as an account handler and held various roles of increasing responsibility through 2022, when she was appointed to CEO of the company's health care unit, according to her LinkedIn profile.

 

Write to Connor Hart at connor.hart@wsj.com

 

(END) Dow Jones Newswires

December 15, 2025 10:04 ET (15:04 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10